PMC6055910_01
Psoriasiform skin lesions in the frontal scalp region (A), palms (B), soles (C), and fingernails (D).
btt-12-069Fig1.jpg
PMC6055910_01_btt-12-069Fig1.jpg
f1-btt-12-069
Two years after the start of treatment, he presented with palmoplantar pustulosis-like eruptions involving the palms of the hands and soles of the feet of both sides, followed by the appearance of scaly eruptions all over the body (Figure 1).
Swelling in the right knee joint (A) and complete healing of the lesion after therapy with ustekinumab (B).
btt-12-069Fig2.jpg
PMC6055910_01_btt-12-069Fig2.jpg
f2-btt-12-069
Eight months after the discontinuation of infliximab, the patient developed painful knee joint swelling (Figure 2A). Soon after the start of this treatment, the arthritis abated (Figure 2B), and within 2 months, the skin symptoms also resolved (PASI 0.8) (Figure 3).
Complete healing after one injection of ustekinumab in the frontal scalp region (A), palms (B), and fingernails (C).
btt-12-069Fig3.jpg
PMC6055910_01_btt-12-069Fig3.jpg
f3-btt-12-069
Soon after the start of this treatment, the arthritis abated (Figure 2B), and within 2 months, the skin symptoms also resolved (PASI 0.8) (Figure 3).